… with thyroid cancer includes postoperative risk assessment based upon prognostic indicators
developed within the Division. Thyroid remnant ablation is reserved for papillary cancer …

… In a series of 1,000 consecutive and unselected autopsies performed at the Mayo Clinic, …
of the thyroid gland. This is a low incidence. Because of the interest at the Mayo Clinic in thyroid …

… Mayo Clinic [23] contained 62% of papillary tumours. Seventy out of 109 cases of nonmedullary
primary thyroid cancer … more than 80% of the thyroid carcinomas treated at the University …

… 2 demonstrates the proportion of PTCs by tumor size seen at the Mayo Clinic from 1936
to … On the other hand, for a very-low-risk thyroid cancer in which the risk of thyroid cancer …

… at the Mayo Clinic for proven primary hyperparathyroidism. Patients who had surgically proven
carcinoma of the thyroid in addition … Patients with medullary carcinoma of the thyroid and …

… did not have pathologic review at Mayo Clinic; and 13 were … the pathologic review and the
clinical scenario indicated an … carcinoma, Graves' disease, and papillary thyroid cancer, and …

… intraluminal laryngeal or tracheal thyroid cancer seen at the Mayo Clinic from 1913 to 1973
… with thyroid cancer were seen during this time. However, only eighteen of these had cancer …

… On December 1, 2013, RFA was implemented at Mayo Clinic … and approved by Mayo Clinic
Institutional Review Board. … From an economic perspective, the cost of RFA at Mayo Clinic is …

… Objectives: Childhood papillary thyroid cancer (CPTC) often presents with advanced disease
but rarely results in cause-specific mortality (CSM). Controversy remains regarding optimal …

… in a patient with a small thyroid nodule, metastatic thyroid carcinoma should be considered.
… thyroid cancer and for screening family members for C-cell hyperplasia or medullary thyroid …